Editor’s Note December 6, 2011

Temperatures are dropping but things are heating up in the healthcare and life science industry.  OneMedForum SF 2012 is around the corner and we are gearing up to present some of the most promising companies and technologies, as well as innovative approaches to funding the growth economy. In this issue:

Kimberly Ha, Global Editor of BioPharm Insight, a Financial Times subsidiary, will moderate a panel discussion at OneMedForum SF 2012 on Investment Trends in Biotechnology. She notes that many big pharma companies are partnering with academic institutions and that oncology, followed by neurology is one of the hottest areas in acquisitions.

Peter Winter, consultant to the biotechnology industry, brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Wound Management Technologies, [WNDM.PK], a OneMedForum SF 2012 presenting company, has signed a letter of intent to acquire Juventus LLC which operates a nationwide distributor network.

The comments are closed.